All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.

Autor: Schlenk, Richard F. *, Doehner, Konstanze, Kerz, Martina *, Hartmann, Frank *, del Valle, Francesco *, Glasmacher, Axel, Pralle, Hans *, Goetze, Katharina *, Koller, Elisabeth *, Gastl, Guenther, Mergenthaler, Hans G., Salwender, Hans *, Kirchen, Heinz *, Haase, Detlef *, Kremers, Stephan *, Nerl, Christoph, Theobald, Matthias *, Matzdorff, Axel C., Ganser, Arnold, Doehner, Hartmut *
Zdroj: In Blood 16 November 2005 106(11):1849-1849
Databáze: ScienceDirect